Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 7/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SLC18A3 | Q16572 | 2/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5349503 | 0.81 | MAPT (0.43) | CNR2CNR1OPRM1OPRD1OPRK1 | |
| SCHEMBL14842579 | 0.81 | CNR2 (0.40) | CNR2CNR1AKR1C1OPRM1OPRD1 | |
| SCHEMBL28740691 | 0.75 | SLC6A2 (0.41) | OPRM1OPRD1OPRK1MEN1SLC6A2 | |
| SCHEMBL4813860 | 0.74 | MEN1 (0.42) | MEN1KMT2A | |
| Cicloxilic Acid SCHEMBL11233561 | 0.73 | CNR2 (0.46) | CNR2CNR1AKR1C1MAPK1OPRM1 | |
| Cicloxilic Acid SCHEMBL866482 | 0.73 | CNR2 (0.46) | CNR2CNR1AKR1C1MAPK1OPRM1 | |
| Cicloxilic Acid SCHEMBL30436810 | 0.73 | CNR2 (0.46) | CNR2CNR1AKR1C1MAPK1OPRM1 | |
| Cicloxilic Acid SCHEMBL866481 | 0.73 | CNR2 (0.46) | CNR2CNR1AKR1C1MAPK1OPRM1 | |
| SCHEMBL11465118 | 0.73 | MAPT (0.54) | CNR2CNR1OPRM1OPRD1OPRK1 | |
| SCHEMBL9618282 | 0.72 | SLC6A9 (0.41) | MAPK1OPRM1OPRD1OPRK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8115029-B2 | Oxidizing a substrate using a catalyst of a complex of cobalt and N-hydroxysuccinimide, N-hydroxyphthalimide, or N-hydroxymaleimide; alkanes, alkenes, cycloalkanes, cycloalkenes, aromatics, aryl aldehydes, aryl carboxylic acids, benzyl alcohols | UNIVERSITY OF KANSAS (US) | 2012-02-14 | — | — | US | disclosed |
| US-8115029-B2 | Oxidizing a substrate using a catalyst of a complex of cobalt and N-hydroxysuccinimide, N-hydroxyphthalimide, or N-hydroxymaleimide; alkanes, alkenes, cycloalkanes, cycloalkenes, aromatics, aryl aldehydes, aryl carboxylic acids, benzyl alcohols | UNIVERSITY OF KANSAS (US) | 2012-02-14 | — | — | US | disclosed |
| US-8115029-B2 | Oxidizing a substrate using a catalyst of a complex of cobalt and N-hydroxysuccinimide, N-hydroxyphthalimide, or N-hydroxymaleimide; alkanes, alkenes, cycloalkanes, cycloalkenes, aromatics, aryl aldehydes, aryl carboxylic acids, benzyl alcohols | UNIVERSITY OF KANSAS (US) | 2012-02-14 | — | — | US | disclosed |
| US-20080139841-A1 | Cobalt-Catalyzed Oxidations in Volumetrically Expanded Liquids by Compressed Gases | UNIVERSITY OF KANSAS (US) | 2008-06-12 | — | — | US | disclosed |
| US-20080139841-A1 | Cobalt-Catalyzed Oxidations in Volumetrically Expanded Liquids by Compressed Gases | UNIVERSITY OF KANSAS (US) | 2008-06-12 | — | — | US | disclosed |
| US-20080139841-A1 | Cobalt-Catalyzed Oxidations in Volumetrically Expanded Liquids by Compressed Gases | UNIVERSITY OF KANSAS (US) | 2008-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139841-A1 | Cobalt-Catalyzed Oxidations in Volumetrically Expanded Liquids by Compressed Gases | HAO2, HMOX2, HAAO | CNR2 353/4885CHRM3 2256/4885CNR1 1331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.